ArticleInvestigative ophthalmology & visual science2025
DJ-1 Protects Human Retinal Endothelial Cells From Diabetes-Related Conditions and Prevents Ischemic Damage in Mouse Retinal Capillaries.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Purpose: Retinal ischemia in diabetic retinopathy (DR) is caused by the apoptosis of capillary pericytes and endothelial cells. In this study, we investigated the role of the Parkinson-associated protein DJ-1 (PARK7) in retinal capillary degeneration. Methods: DJ-1 levels were measured in diabetic and non-diabetic human retinas by immunostaining and Western blotting. Human retinal endothelial cells (HRECs) were cultured in high glucose or with a cytokine mixture (CM). The effect of inhibition of DJ-1 in HREC with isatin on Nε-carboxymethyl lysine (CML), inducible nitric oxide synthase (iNOS), nuclear factor erythroid 2-related factor (Nrf2), nuclear factor kappa (NF-κB), and cleaved caspase-3 was investigated. AAV2-PARK7, driven by the endothelial cell-specific Tie2 promoter, was intravitreally injected into the mouse's eyes, and the effect of the retinal transduced DJ-1 on capillaries was investigated following ischemia/reperfusion injury. Results: DJ-1 levels were observed to be reduced in human retinas with DR and in HREC cultured under high-glucose conditions. Isatin treatment increased the CML and iNOS levels in HREC. Treatment of HREC with CM promoted nuclear translocation of NF-κB and activation of caspase-3; co-treatment with isatin further exacerbated these effects. Isatin treatment significantly suppressed the CM-induced Nrf2 translocation in HREC. Intravitreal injection of AAV2-tie2-PARK7 resulted in high expression of DJ-1 in retinal capillaries and significantly reduced formation of acellular capillaries from ischemia/reperfusion injury. Conclusions: The results suggest that DJ-1 protects retinal capillary endothelial cells from damage caused by hyperglycemia and ischemia and that enhancing DJ-1 activity could be a strategy for mitigating early retinal damage in DR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.